Figure 2.

Disease-related concentrations of high density lipoprotein (HDL), low density lipoprotein (LDL) and total cholesterol (TC) assessed based on positivity to MAP antigens. The analysis was performed by comparing MAP+ versus MAP- subjects among patients affected by MS (A–C), at risk of T1DM (rT1DM) (D–F) and RA subjects (G–I). Additionally, a comparison of patients and healthy controls (HCs) was carried out for the same MAP-related serological status. Statistical significance is reported above relative bars when attained. For each group, standard deviation is indicated.